TheraRadar
Data updated: May 26, 2026

FOCALIN (dexmethylphenidate hydrochloride)

CNS Approved 2001-11-13

Focalin is a central nervous system stimulant used for patients with Attention Deficit Hyperactivity Disorder (ADHD). It helps individuals manage the symptoms associated with this condition by acting on the brain and nerves. This medication is typically prescribed to help improve focus and control impulsivity in those diagnosed with ADHD.

Source: FDA Label • Novartis

How FOCALIN Works

Focalin works by stimulating the central nervous system. Although it is effective for managing symptoms, the specific way the drug produces its therapeutic effect in patients with ADHD is not currently known.

1
Indication
--
Phase 3 Trials
24
Years on Market

Details

Status
Prescription
First Approved
2001-11-13
Routes
ORAL
Dosage Forms
TABLET

Companies

FOCALIN Approval History

2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
63 FDA actions from 2001 to 2023
Oct 2023 SUPPL
Label · Labeling
Jun 2021 SUPPL
Label · Labeling
Nov 2019 SUPPL
Label · Labeling

What FOCALIN Treats

1 indications

FOCALIN is approved for 1 conditions since its original approval in 2001. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Attention Deficit Hyperactivity Disorder
Source: FDA Label

FOCALIN Boxed Warning

ABUSE, MISUSE, AND ADDICTION Focalin has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including Focalin, can result in overdose and death [see Overdosage ( 10 )] , and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection. Before prescribing Focalin, assess each patient’s risk for abuse, misuse, and addiction. Educate patients...

FOCALIN Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to FOCALIN

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ADDERALL XR 10
AMPHETAMINE ASPARTATE
1 shared
Takeda
ADDERALL XR 15
AMPHETAMINE ASPARTATE
1 shared
Takeda
ADDERALL XR 20
AMPHETAMINE ASPARTATE
1 shared
Takeda
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

FOCALIN FDA Label Details

Indications & Usage

FDA Label (PDF)

FOCALIN is indicated for the treatment of Attention Deficit Hyperactivity Disorder.

⚠️ BOXED WARNING

WARNING: ABUSE, MISUSE, AND ADDICTION Focalin has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including Focalin, can result in overdose and death [see Overdosage ( 10 )] , and this risk...

Track FOCALIN with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.